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Abstract 
As a stenosis becomes more severe, blood flow through it increases in velocity to maintain 
volume, flow and pressure. But there is a critical point beyond which further increase in 
stenosis no longer allows sufficient blood to pass through to maintain volumetric flow, and 
the carotid artery beyond the stenosis begins to decrease in diameter. This is the near 
occlusion. To maintain a sufficient blood flow in affected area, there is a progressive 
recruitment of collaterals followed by an activation of cerebral autoregulation with dilatation of 
resistance vessels. When this process fails to maintain normal CBF, oxygen extraction 
fraction of the affected brain tissue increases to maintain normal cerebral metabolism. Near 
occlusion has been described as involving 1 to 10% of all severe stenosis, but the potential 
for stroke from such critical stenosis is less than its appearance would suggest. The optimum 
management of near-occlusion therefore remains a matter of debate. Although 
endarterectomy for carotid stenosis of 70-99% was associated with an absolute risk 
reduction in any stroke or death of 16% in the original randomised trials, the benefit was less 
in patients with near-occlusion. In 2015, a meta-analysis focused on patients with near-
occlusion confirmed only a small benefit of CEA or CAS compared to medical treatment in 
patients with near occlusion. In patients with near-occlusion and compromised 
haemodynamics, revascularization should improve cerebral blood flow and consequently 
prevent ischaemic stroke. Nevertheless the effect of improved cerebral haemodynamics after 




Stroke is the second most common cause of mortality and the third most common cause of 
disability worldwide. The TOAST classification is commonly used to differentiate stroke 
etiology,1 but in this classification patients with near or total occlusion are not separately 
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identified, and most will be included within the category of large-artery atherosclerosis. This 
makes it difficult to estimate the prevalence of patients with near or total occlusion. Overall, 
15-20% of strokes are related to an atherosclerotic stenosis of the internal carotid artery 
(ICA) and its prevalence increases with age and risk factors in western countries. It is 
generally assumed that a stenosis is considered a symptomatic stenosis when the ischaemic 
lesion causing the stroke is within an appropriate ipsilateral carotid artery distribution in the 
presence of a significant degree of stenosis, usually considered to be one that is >50% 
measured using the NASCET method.  The prevalence of asymptomatic carotid artery 
stenosis >50% in the general population is estimated at 4.8% for men and 2.2% for women. 
The prevalence increases significantly after 70 years old.2 Low-grade internal carotid artery 
(ICA) stenosis (<50%) has a risk of 4 to 29% of progressing to a higher grade of stenosis and 
is then associated with an increasing risk of stroke.3 Indeed, some studies have suggested 
that the risk of stroke in low-grade stenosis starts at 7.8% and rises to 18.5% in high-grade 
stenosis in initially asymptomatic patients with a similar gradient in symptomatic patients from 
18.7 to 27%.4 Nevertheless, there is a point towards occlusion where the risk of stroke 
begins to decline despite the severity of the stenosis, which is a feature of near-occlusion of 
the carotid artery (Figure 1).  
 
The features of near-occlusion were drawn to attention by Lippman et al in 1970, using the 
descriptive term of the post-stenotic slim sign. Other appellations for the same phenomenon 
include pseudo-occlusion, the nearly-occluded carotid artery, string sign and carotid collapse. 
The prevalence has been described from 1 to 10% of all severe stenosis, but it is clear that 
the potential for stroke from such critical stenosis is less than its appearance would suggest.5 
Moreover, although the management of severe carotid stenosis has been extensively 
studied, the optimum management of near-occlusion of the ICA still remains a matter of 
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Atherosclerosis is as diffuse and degenerative disease of the arteries resulting in plaque and 
vessel narrowing and leading to ischaemic stroke or transient ischaemic attack (TIA). 
Plaques consist of necrotic cells, lipids and cholesterol crystals. The most frequent location 
of carotid atherosclerosis is the carotid bifurcation with extension into the proximal internal 
carotid artery. As a stenosis progressively becomes more severe, blood flow through it 
increases in velocity to maintain volume, flow and pressure. But there is a critical point 
beyond which further increase in stenosis no longer allow sufficient blood to pass through 
and the ICA beyond the stenosis begins to decrease in diameter. This defines ICA near-
occlusion and in many cases, the stenosis will progress to complete occlusion. The 
hemispheric circulation is then supplied through inverted ophthalmic artery blood flow from 
the external carotid or by the contralateral ICA or vertebrobasilar circulation through the 
communicating arteries. Less commonly collaterals may come from the leptomeningial 
arteries or the cortical surface branches.  
If collateralisation is not sufficient to maintain normal blood flow in affected areas, the flow 
can be maintain by dilatation of the resistance vessels. This is cerebral autoregulation or 
cerebral vasoreactivity (CVR). This process is diagnosed by reduced or absent cerebral 
blood flow (CBF) response to vasodilate stimuli such as hypercapnia in the cerebrovascular 
reactivity test. In ICA occlusion, this vasodilatative stimulus may not increase CBF if 
autoregulation has already caused maximal vasodilatation in response to the low cerebral 
perfusion pressure. This was shown by Oka et al in 2013 using SPECT to quantify resting 
CBF in near-occlusion compared to severe stenosis without near-occlusion.6 Resting CBF 
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and CVR were both significantly lower in the patients with near-occlusion, consistent with the 
hypothesis of compromised haemodynamics in these patients.  
Finally, when this process fails to maintain normal CBF, oxygen extraction fraction of the 
affected brain tissue increases to maintain normal cerebral metabolism. This is a 
haemodynamic failure or misery perfusion. An increase oxygen extraction fraction is an 
independent risk factor for subsequent ischaemic strokes in patients with symptomatic ICA 
occlusion. The annual stroke risk in patients with impaired haemodynamic measurements of 
any severity was 12.5% for all strokes and 9.5% for ipsilateral strokes. This highlights the 
worse prognosis in patients with impaired cerebral perfusion than in those without. CVR is an 
alternative parameter for predicting long-term outcome but its validity is still controversial. In 
their study, Kuroda et al. determined that CVR to acetazolamide is a reliable predictor of 
subsequent ischaemic stroke in medically treated patients with occlusive carotid disease.7 
The overall annual rate for total and ipsilateral stroke was 5.8% and 2.6% respectively. The 
study demonstrated the higher risk of ipsilateral stroke and total ischaemic stroke in patients 
with decreased CVR. 
 
Clinical presentation 
Cardiovascular events and deaths are more frequent in patients with near-occlusion than in 
those without. This is in line with the fact that patients with severe stenosis sufficient to cause 
carotid artery collapse may also suffer from severe atherosclerosis throughout the body.  
The clinical spectrum of ICA occlusion ranges from being completely asymptomatic to 
devastating stroke or death. ICA occlusion is also an independent predictor of neurological 
worsening in stroke.8 
 
Clinical presentation of a near-occluded or occluded ICA is very varied. If collateral flow is 
inadequate, stroke may result directly from the reduction in flow but more commonly stroke 
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associated with carotid occlusion is embolic. Embolic TIA or stroke presents with clinical 
features similar to those due to any other etiology. However, a haemodynamic condition that 
reduces cerebral perfusion, such as postprandial hypotension, fluid or blood loss, exercise or 
cardiac failure can lead to a stroke from haemodynamic mechanisms. A rare manifestation of 
haemodynamic compromise is limb shaking which could be misdiagnosed as partial 
seizures. Some patients develop headaches in chronic occlusion due to the development of 
collateral circulation. Collateral flow from the external carotid may also cause ipsilateral 
pulsation at the angle of the jaw, brow and cheek known as the ABC pulsation of Fisher.9 
This is not seen when collaterals arise from circle of Willis. In 4-18% of patients with 
occlusion or severe stenosis of the ICA a syndrome of chronic ocular ischaemia may 
develop. Patients complain of progressive loss of visual acuity. Although, emboli arising from 
a clot within evolving occlusion is the commonest mechanism of stroke, Molloy and Markus 
showed that there is a significant reduction in the number of microemboli detected using 
transcranial Doppler when the degree of stenosis is higher than 90% and particularly in 
patients with post-stenotic narrowing and blood flow reduction.10 This is in keeping with the 
observation that the incidence of ischaemic stroke in medically treated patients with near-
occlusion are lower than in patients with severe stenosis without near-occlusion. 
 
Imaging  
Nowadays, catheter-based cerebral angiography (DSA) has been almost completely 
removed from the standard assessment of carotid disease because of its invasive nature and 
risk. Current imaging methods for routine assessment include duplex ultrasound (DUS), 
computed tomography angiography (CTA) and magnetic resonance angiography (MRA). All 
three have a good sensitivity and specificity to estimate high-grade stenosis. DUS is used to 
detect focal increases in blood flow velocity indicative of high-grade stenosis, but is less 
precise in smaller stenosis and calcified arteries. It operator-dependency makes it also less 
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reliable. CTA provides an anatomic view of the carotid artery lumen, allows for evaluation of 
the intracranial and extracranial circulation and evaluation of adjacent soft tissue and bone 
structure. TOF-MRA is very sensitive in arterial stenosis but tends to overestimate stenosis. 
Contrast-enhanced MR has the advantage of not being limited by calcification (Figure 2). It 
was considered to be the most accurate non-invasive test for carotid artery stenosis by 
Chappell et al in 2009,11 but many would argue that CTA is now the more accurate modality, 
especially in the absence of calcification.  
 
It becomes technically challenging to accurately visualise a near-total occlusion and to 
differentiate it from a total occlusion of the carotid using these non-invasive methods. The 
diagnosis of near-occlusion based on DSA uses 4 criteria: 1) delayed time of contrast arrival 
in the ICA compared to the filling of the ECA, 2) evidence of collaterals (anterior or posterior 
communicating arteries, external carotid collaterals (usually ophthalmic), 3) ICA-to-ICA 
comparison of diameter reduction and 4) ICA-to-ECA comparison of diameter reduction. The 
delayed of contrast arrival has the poorest sensitivity for diagnosing near-occlusion (37.5%) 
whereas ICA to ECA comparison of diameter reduction had the highest sensibility (84.4%).12  
 
A part from DSA, CT angiography can distinguish near-occlusion from total ICA occlusion 
with a high degree of accuracy but gives no information about blood flow velocity and 
directionality. With DUS, some symptomatic patients with near-occlusion stenosis are 
wrongly classified as having occlusion, because of the very low flow in the vessel13. Newer 
techniques with contrast-enhanced agent or modified duplex protocol have shown to be 
effective in distinguishing between occlusion and pseudo-occlusion.13 
MR angiography is generally accurate in identifying total and near-occlusion from the ICA 
origin to the supraclinoid part (figure 2). However, the appearances can be disguised by the 
presence of collateral flow distal to the occlusion, without the ability on MRA to define the 
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flow direction or sequence of vessel filling. Gadolinium contrast-enhanced MR angiography 
(CEMRA) is better than the TOF angiography for depicting near-occlusion. In current practice 
the combination of CEMRA or CTA and CDUS is considered sufficient for identifying patients 
with carotid artery occlusion.  
 
Perfusion imaging 
The techniques mentioned above are able to identify a near-occlusion of the carotid but 
provide no consideration of the haemodynamic compromise. The evaluation of cerebral 
perfusion and blood supply can be assessed by SPECT, PET, functional MRI and perfusion 
or Xenon CT. Transcranial ultrasound (breath holding test) and quantitative MRA also 
evaluate cerebral vasoreactivity and PET quantifies the oxygen extraction fraction.  
 
Treatment 
The correct grading of the carotid stenosis is essential to guide the options for treatment. 
While carotid endarterectomy and endovascular treatment have been proved superior to best 
medical treatment (defined as treatment of risk factors, modification of lifestyle and medical 
treatment with aspirin or combination of aspirin and dypirydamole or clopidogrel) in high-
grade stenosis,15 it remains a matter of debate whether the near-occluded carotid should be 
revascularised or not.  In general, revascularisation is not an option for total carotid 
occlusion, unless perhaps in the hyperacute case, where the artery can be re-opened within 
a few hours of onset of the occlusion.  
 
High-grade stenosis 
Concerning high-grade carotid stenosis, two landmark large trials, the North American 
Symptomatic Carotid Endarterectomy Trial (NASCET) and the European Carotid Surgery 
Trial (ECST) showed a benefit of carotid endarterectomy (CEA) over medical treatment in 
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patients with more than 70% symptomatic internal carotid artery stenosis. Pooled analysis of 
these trials showed an absolute risk reduction in any stroke or death of 16% (p<0.001) and a 
number needed to treat of 6 in patients with a stenosis of 70-99%.15 Moreover, CEA within 
two weeks of a non-disabling stroke or TIA significantly lowered the stroke risk compared 
with later surgery. Carotid endarterectomy in asymptomatic patients with a stenosis greater 
than 60% also showed a benefit in the Asymptomatic Carotid Surgery Trial (ACST), although 
the benefit was much weaker.15 The net five-year risk for all strokes or perioperative death in 
the immediate CEA group was reduced by nearly half compared with the CEA deferral group 
(6.9 versus 10.9%; p=0.001).  
 
Near-occlusion 
In near-total occlusion the decision for or against revascularization still remains controversial.  
The decision should take into account the evidence that ICA occlusion will occur in 
approximately 40% of the patients within 12 months or in 100% within 34 months. 
Cerebrovascular or cardiac events are more frequent in patients with near-total ICA 
occlusion compared with patients with carotid artery stenosis. But, on the other hand, the 
reduction of blood flow across the stenosis may reduce the risk of brain embolization10. 
Nowadays, data are limited since this group of patients were excluded from some of the 
biggest carotid trials, including CREST and ICSS. The available data originate from the post-
hoc analyses of the large trials performed in the late 1990s (NASCET, ECST). In NASCET, 
the 3-years risk of ipsilateral stroke for surgically vs. medically treated patients was 11.4% vs 
17.9% respectively. In ECST, the 3-year risk was 10.5% vs. 11.1% respectively.12 The 
difference between both studies was explained by the lower prevalence of some risk factors 
in the ECST trial. In 2005, Fox et al. merged the two trials ECST and NASCET and evaluated 
all patients with severe stenosis.12 The combined results of these studies showed a low risk 
of stroke in the medically treated patients with near-occlusion (Figure 3).15 This provided 
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again evidence that most strokes arising from a narrowed artery are embolic rather than 
haemodynamic. In 2015, a meta-analysis focused on patients with near-occlusion confirmed 
again the small benefit of CEA or carotid artery stenting (CAS) compared to medical 
treatment in these patients and balanced their results with the improvement of the medical 
therapy and lifestyle recommendation in the last 20 years. No difference was found between 
CEA and CAS concerning TIA or stroke risk, but a borderline significance was recorded 
concerning overall mortality favouring CEA compared to CAS (p=0.08) and restenosis 
favouring CAS compared to CEA (0.08).16 
 
In patients with near-occlusion and compromised haemodynamics, revascularization should 
improve cerebral blood flow and consequently prevent ischaemic stroke. In 2013, Oka et al 
used SPECT imaging to investigate the haemodynamic effects of CAS in patients with near-
occlusion in comparison with patient with stenosis without near-occlusion.6 After CAS, the 
mean resting CBF and CVR were both significantly increased in patients with near-occlusion. 
The study showed that cerebral haemodynamics were compromised in patients with near-
occlusion and both CBF and CVR increased after revascularization. Nevertheless the effect 
of improved cerebral haemodynamics after revascularization on prevention of ischaemic 
stroke is uncertain. In another study comparing CEA and cognitive function, it appeared that 
cognitive changes are proportionally related to the metabolism in the cerebral hemisphere 
ipsilateral to CEA. Post CEA recovery of cerebral metabolism resulted in postoperative 
cognitive improvement and the inverse was also true.17 
 
Carotid occlusion  
In carotid occlusion, one has to consider acute and the chronic occlusion separately, 
because they are two different entities in terms of management. Acute occlusion of the 
carotid, if symptomatic often presents as a massive stroke with high NIHSS (national 
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Institutes of Health Stroke Scale) related to profound neurological deficit. Acute ICA 
occlusion has a poor prognosis even with systemic thrombolysis, which is the first line of 
treatment in any acute ischaemic stroke. The second line of treatment of acute ICA occlusion 
involves mechanical thrombectomy. The third line of treatment involves surgery in some very 
rare and selected cases. Patients with mild or improving neurologic deficits, no evidence of 
haemorrhagic infarct on CT and a recent ICA thrombosis with a patent distal ICA could be 
considered as candidates for a surgical approach. 
 
As mentioned above, some patients will evolve from a high-grade stenosis to a total 
occlusion and then have chronic occlusion, which can remain asymptomatic through life. One 
study established that the 2-year risk of ipsilateral ischaemic stroke following internal carotid 
artery occlusion in patients undergoing maximal medical therapy is 5-8% per year.18 In a 
recent retrospective study, the authors showed 0.3% rate of stroke related to progression to 
carotid occlusion in 316 carotid stenosis evaluated from 1990 to 2012.19 The authors 
concluded that preventing carotid occlusion should no longer be regarded as an indication for 
carotid revascularisation.  
 
In the 1960s, it was common to believe that patients with carotid occlusion could be 
successfully treated by bypass surgery. In 1977, the first prospective randomized trial on 
extracranial-intracranial (EC-IC) bypass in conjunction with best medical therapy showed no 
statistical difference in outcomes between the 2 cohorts neither within 30 days nor in the long 
term. The rate of recurrent stroke in the bypass group was 31% vs 29% in the medical 
therapy alone group. Later the observational St Louis Carotid occlusion study (STLCOS) 
demonstrated that ipsilateral increased oxygen extraction fraction (OEF) is an independent 
risk factor for subsequent stroke in symptomatic patients (5.3% stroke risk in 42 patients with 
normal OEF and 26.5% in 39 patients with increased OEF; p=0.040). The authors suggested 
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that selection using PET should be considered as a preliminary to bypass surgery. In 2011 
the carotid occlusion surgery study (COSS), showed that despite improved cerebral 
haemodynamics with reduced OEF on follow-up PET, there was no benefit to EC-IC bypass 
surgery and no difference in event rates between the medical and surgical groups was found. 
Nevertheless, it was suggested that a longer 5-year follow-up would have shown a benefit of 
surgery and that bypass should still be considered a viable option in a very select patient 
population (those with severe haemodynamic compromise whose symptoms are refractory, 
postural or blood pressure dependent).20 
 
Surgery complications 
Severely impaired autoregulatory mechanisms, as seen in near-occlusion, have been 
suggested as a risk factor for developing cerebral hyperperfusion syndrome. The same 
correlation is true with regard to the degree of stenosis. The presence of good ipsilateral and 
collateral circulation can help reduce the ischaemic damage. The hyperperfusion syndrome 
arises when blood is restored after intervention and altered starling forces promote oedema 
formation. Vessels are no longer able to constrict to reduce hydrostatic pressure and 
increased membrane permeability promotes oedema and haemorrhage. Free radicals will 
further damage cells and predispose to neuronal damage. Symptoms can be various 
including change in mental status, headaches, seizure and focal neurologic deficit. 
Symptoms generally occur within four to seven days after a carotid endarterectomy and can 
come earlier after stenting. Patients who developed the syndrome have by definition a 
pressure-dependent blood flow and management includes tight control of blood pressure.   
 
Conclusion 
Carotid stenosis is an important cause of stroke and the risk increases as the artery 
becomes more narrowed. This is true until a certain critical point, the point of near-occlusion 
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of the carotid. This is the point, just before occlusion, where the blood flow decreases and 
the survival mechanisms may intervene to prevent ischaemia. These mechanisms include 
formation of collaterals, vascular autoregulation with vasodilation and increment in the 
oxygen extraction fraction by the tissue. Although carotid surgery and endovascular 
treatment are the gold standard treatment for cases of severe symptomatic stenosis, the 
optimum treatment of near-occlusion stenosis is still under debate. Considering the risk of 
embolism, the evidence suggests that the surgical risk is higher than the carotid risk by itself, 
although a prospective study using current treatment modalities is needed to confirm this 
view. Regarding the haemodynamic point of view, surgery seems clearly logical to improve 
cerebral blood flow in these patients.  But how much this will improve the risk of stroke and 
result in cognitive improvement remain controversial. 
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Figure 1: 5-year risks of ipsilateral stroke on the sides of the symptomatic and asymptomatic 
carotid stenosis treated medically in 1820 patients included in NASCET. Data extracted from 
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Figure 2: Contrast-enhanced magnetic resonance angiogram showing near occlusion of the 
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Figure 3: Absolute risk reduction (ARR) in the rate of ipsilateral ischaemic stroke and any 
operative stroke or operative death at 3, 5, and 8 years’ follow-up associated with surgery at 
different degrees of stenosis (NASCET measurement) in an analysis of pooled data from 
ECST and NASCET. The box on the right hand side of the figure draws attention to lack of 
benefit in patients near-occlusion compared to patients with 90-99% stenosis without near-
occlusion. Figure taken from Rothwell et al 200315 with permission. 
 
 
 
 
 
 
 
